These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
329 related items for PubMed ID: 16330163
1. Rationale and perspectives on the success of vaccination against bovine herpesvirus-1. van Drunen Littel-van den Hurk S. Vet Microbiol; 2006 Mar 31; 113(3-4):275-82. PubMed ID: 16330163 [Abstract] [Full Text] [Related]
2. A live bovine herpesvirus-1 marker vaccine is not shed after intramuscular vaccination. Makoschey B, Beer M. Berl Munch Tierarztl Wochenschr; 2007 Mar 31; 120(11-12):480-2. PubMed ID: 18085158 [Abstract] [Full Text] [Related]
3. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge. Silva AD, Spilki FR, Franco AC, Esteves PA, Hübner SO, Driemeier D, Oliveira AP, Rijsewijk F, Roehe PM. Vaccine; 2006 Apr 12; 24(16):3313-20. PubMed ID: 16480790 [Abstract] [Full Text] [Related]
4. Cell-mediated immune responses induced by BHV-1: rational vaccine design. van Drunen Littel-van den Hurk S. Expert Rev Vaccines; 2007 Jun 12; 6(3):369-80. PubMed ID: 17542752 [Abstract] [Full Text] [Related]
5. [Conventional and marked BHV-1 vaccines in Germany: a brief review]. Trapp S, König P, Beer M. Berl Munch Tierarztl Wochenschr; 2003 Jun 12; 116(5-6):208-15. PubMed ID: 12784554 [Abstract] [Full Text] [Related]
6. Efficacy of a temperature-sensitive modified-live bovine herpesvirus type-1 vaccine against abortion and stillbirth in pregnant heifers. Cravens RL, Ellsworth MA, Sorensen CD, White AK. J Am Vet Med Assoc; 1996 Jun 15; 208(12):2031-4. PubMed ID: 8707679 [Abstract] [Full Text] [Related]
7. Infectious bovine rhinotracheitis: study on the experimentally induced disease and its prevention using an inactivated, adjuvanted vaccine. Soulebot JP, Guillemin F, Brun A, Dubourget P, Espinasse J, Terre J. Dev Biol Stand; 1982 Jun 15; 52():463-83. PubMed ID: 6299856 [Abstract] [Full Text] [Related]
8. Evaluation of the efficacy of a modified-live combination vaccine against abortion caused by virulent bovine herpesvirus type 1 in a one-year duration-of-immunity study. Ficken MD, Ellsworth MA, Tucker CM. Vet Ther; 2006 Jun 15; 7(3):275-82. PubMed ID: 17039450 [Abstract] [Full Text] [Related]
9. Partial protection induced by a BHV-1 recombinant vaccine against challenge with BHV-5. Spilki FR, Silva AD, Hübner S, Esteves PA, Franco AC, Driemeier D, Roehe PM. Ann N Y Acad Sci; 2004 Oct 15; 1026():247-50. PubMed ID: 15604501 [Abstract] [Full Text] [Related]
10. Rapid onset of protection following vaccination of calves with multivalent vaccines containing modified-live or modified-live and killed BHV-1 is associated with virus-specific interferon gamma production. Woolums AR, Siger L, Johnson S, Gallo G, Conlon J. Vaccine; 2003 Mar 07; 21(11-12):1158-64. PubMed ID: 12559793 [Abstract] [Full Text] [Related]
11. Effect of vaccination against bovine herpesvirus 1 with inactivated gE-negative marker vaccines on the health of dairy cattle herds. Raaperi K, Orro T, Viltrop A. Prev Vet Med; 2015 Mar 01; 118(4):467-76. PubMed ID: 25662288 [Abstract] [Full Text] [Related]
12. The use of marker vaccines in eradication of herpesviruses. van Oirschot JT, Kaashoek MJ, Rijsewijk FA, Stegeman JA. J Biotechnol; 1996 Jan 26; 44(1-3):75-81. PubMed ID: 8717389 [Abstract] [Full Text] [Related]
19. BHV-1 vaccine induces cross-protection against BHV-5 disease in cattle. Del Médico Zajac MP, Puntel M, Zamorano PI, Sadir AM, Romera SA. Res Vet Sci; 2006 Dec 26; 81(3):327-34. PubMed ID: 16540133 [Abstract] [Full Text] [Related]
20. [Diagnostic markers in the prevention of bovine herpesvirus type 1: possibilities and limitations]. Beer M, König P, Schielke G, Trapp S. Berl Munch Tierarztl Wochenschr; 2003 Dec 26; 116(5-6):183-91. PubMed ID: 12784550 [Abstract] [Full Text] [Related] Page: [Next] [New Search]